Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maspero

Showing results (511-520 of 536) with videos related to

Pageof 54
Sort By:
The Lancet. Respiratory Medicine|October 1, 2021
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension studyMichael E Wechsler, Linda B Ford, Jorge F Maspero, et al.
The World Allergy Organization Journal|November 21, 2024
Corrigendum to "Epidemiology of adult patients with atopic dermatitis in AWARE 1: A second international survey" [World Allergy Organ J 16 (3) (2023) 100724]Jorge Maspero, Norma De Paula Motta Rubini, Jianzhong Zhang, et al.
Cell Reports|September 15, 2021
The prolyl-isomerase PIN1 is essential for nuclear Lamin-B structure and function and protects heterochromatin under mechanical stressFrancesco Napoletano, Gloria Ferrari Bravo, Ilaria Anna Pia Voto, et al.
The World Allergy Organization Journal|April 10, 2023
Epidemiology of adult patients with atopic dermatitis in AWARE 1: A second international surveyJorge Maspero, Norma De Paula Motta Rubini, Jianzhong Zhang, et al.
International Journal of Molecular Sciences|April 12, 2022
Benefits and Implications of Resveratrol Supplementation on Microbiota Modulations: A Systematic Review of the LiteratureAlessio Danilo Inchingolo, Giuseppina Malcangi, Angelo Michele Inchingolo, et al.
Lancet (London, England)|September 24, 2019
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trialsClaus Bachert, Joseph K Han, Martin Desrosiers, et al.
Chest|January 26, 2026
Interactive Pathways of Key Prognostic Factors in Severe Asthma: A Bayesian Network Comparison of Clinical Trials & Real-World DataChandra Prakash Yadav, Laura Huey Mien Lim, David Price, et al.
Pragmatic and Observational Research|October 26, 2023
Adult Severe Asthma Registries: A Global and Growing InventoryBreda Cushen, Mariko Siyue Koh, Trung N Tran, et al.
Medical Image Analysis|May 26, 2026
MRIgRT real-time target tracking: TrackRAD2025 challenge reportTom Julius Blöcker, Pia A W Görts, Yiling Wang, et al.
Chest|February 23, 2024
International Variation in Severe Exacerbation Rates in Patients With Severe AsthmaTae Yoon Lee, David Price, Chandra Prakash Yadav, et al.
Pageof 54

Showing results (511-520 of 536) with videos related to

Sort By:
Pageof 54
The Lancet. Respiratory Medicine|October 1, 2021
Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension studyMichael E Wechsler, Linda B Ford, Jorge F Maspero, et al.
The World Allergy Organization Journal|November 21, 2024
Corrigendum to "Epidemiology of adult patients with atopic dermatitis in AWARE 1: A second international survey" [World Allergy Organ J 16 (3) (2023) 100724]Jorge Maspero, Norma De Paula Motta Rubini, Jianzhong Zhang, et al.
Cell Reports|September 15, 2021
The prolyl-isomerase PIN1 is essential for nuclear Lamin-B structure and function and protects heterochromatin under mechanical stressFrancesco Napoletano, Gloria Ferrari Bravo, Ilaria Anna Pia Voto, et al.
The World Allergy Organization Journal|April 10, 2023
Epidemiology of adult patients with atopic dermatitis in AWARE 1: A second international surveyJorge Maspero, Norma De Paula Motta Rubini, Jianzhong Zhang, et al.
International Journal of Molecular Sciences|April 12, 2022
Benefits and Implications of Resveratrol Supplementation on Microbiota Modulations: A Systematic Review of the LiteratureAlessio Danilo Inchingolo, Giuseppina Malcangi, Angelo Michele Inchingolo, et al.
Lancet (London, England)|September 24, 2019
Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trialsClaus Bachert, Joseph K Han, Martin Desrosiers, et al.
Chest|January 26, 2026
Interactive Pathways of Key Prognostic Factors in Severe Asthma: A Bayesian Network Comparison of Clinical Trials & Real-World DataChandra Prakash Yadav, Laura Huey Mien Lim, David Price, et al.
Pragmatic and Observational Research|October 26, 2023
Adult Severe Asthma Registries: A Global and Growing InventoryBreda Cushen, Mariko Siyue Koh, Trung N Tran, et al.
Medical Image Analysis|May 26, 2026
MRIgRT real-time target tracking: TrackRAD2025 challenge reportTom Julius Blöcker, Pia A W Görts, Yiling Wang, et al.
Chest|February 23, 2024
International Variation in Severe Exacerbation Rates in Patients With Severe AsthmaTae Yoon Lee, David Price, Chandra Prakash Yadav, et al.
Pageof 54